Subclinical AtrIal FibrilLation and StrokE PreveNtion Trial
A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 2054 participants.
Also called NCT02004509
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 2,054 participants
- Sponsor
- Registry
-
NCT02004509
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Brazil
- Registry status
- Unknown status
Technical summary
Registry record NCT02004509. Randomized; no masking; primary purpose treatment. Start 2015-02-06 (actual); primary completion 2025-10-31 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Subclinical AtrIal FibrilLation and StrokE PreveNtion Trial
- Acronym
- SILENT
- Condition
- Atrial Fibrillation
- Intervention (Drug)
- Anticoagulant
- Lead sponsor
- InCor Heart Institute
Record details
- Record id
cardio:ct-nct02004509- Content hash
1bc2ecbe86b3394c973e7e9d4bfaa0b0a7994922a530bd758fc8c3f7b52ba4fc